Porphyrin Derivatives Inhibit the Interaction between Receptor Activator of NF-κB and Its Ligand.

about

Porphyrin Derivatives Inhibit the Interaction between Receptor Activator of NF-κB and Its Ligand.

Item

http://www.wikidata.org/entity/Q47834751

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@en

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@nl

type

Item

label

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@en

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@nl

prefLabel

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@en

Porphyrin Derivatives Inhibit ...... vator of NF-κB and Its Ligand.

@nl

P1476

Porphyrin Derivatives Inhibit ...... ivator of NF-κB and Its Ligand

@en

P2093

Christophe Morice

http://www.w3.org/2001/XMLSchema#string

Maria-Bernadette Madel

http://www.w3.org/2001/XMLSchema#string

Mélanie Chypre

http://www.w3.org/2001/XMLSchema#string

Olivier Chaloin

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity

Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.

Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.

P304

1697-1702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700462

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher G Mueller

C Blin-Wakkach

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28885764

http://www.w3.org/2001/XMLSchema#string

P921

NF-κB